Preventive and Therapeutic Interventions for Anticancer Drug-induced Dermatologic Toxicities: a Scoping Review.

Life-saving cancer drugs often come with a harsh side effect: severe skin reactions. These skin issues can be so debilitating that some patients struggle to stick with their treatments. To figure out the best ways to soothe and prevent these conditions, researchers recently conducted a scoping review, which is a broad analysis of existing research. They systematically mapped out data from 51 different clinical studies to see which interventions actually work for specific drug-induced skin problems.

The main takeaway is that treating these skin reactions requires a highly customized approach because different drugs damage the skin in completely different ways. For example, cancer medications called EGFR inhibitors often cause an inflammatory rash. The review found this is best prevented using a combination of specific antibiotics, like tetracyclines or macrolides, paired with topical steroid creams. Conversely, a chemotherapy drug named capecitabine can cause a painful condition called hand-foot syndrome. For this issue, researchers found success using COX-2 inhibitors, which are targeted anti-inflammatory drugs, as well as methylcobalamin, a form of vitamin B12 that has shown strong results in late-stage clinical trials.

Ultimately, the researchers concluded that doctors must ditch the standard, universal approach to skin care. Instead, matching the treatment to the specific biological mechanism of the skin reaction is the most effective strategy. Readers should note that because this is a scoping review, the findings rely on combining previously published studies of varying sizes and designs, rather than data from a brand-new, uniform clinical trial.